Molecular Templates Inc at UBS Global Healthcare Conference Transcript

May 20, 2019 / 12:00PM GMT
Carter Lewis Gould - UBS Investment Bank, Research Division - Large Cap Biotech Analyst

Great. Good morning. My name is Carter Gould, senior analyst here at UBS covering biotech sector. We're going to kick things off this morning by introducing Molecular Templates. We have the CEO and Founder, Dr. Eric Poma, here. When we look, we have a number of, sort of, antibody-based companies or companies in the antibody space that come across our desk, but I would argue Molecular Templates is one of the definitely unique and novel platforms that we've seen in some time.

Questions and Answers:

Carter Lewis Gould - UBS Investment Bank, Research Division - Large Cap Biotech Analyst

And so I guess maybe to kick things off, it would be helpful if, Eric, maybe you give us a little bit of background of technology and the company.

Eric E. Poma - Molecular Templates, Inc. - CEO, Chief Scientific Officer & Director

Sure. So the company was founded 10 years ago. Our goal was to really build a new mechanism of action in oncology.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot